Found 0 matching trials
Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT PHASE2 This is a prospective study comparing autologous hematopoietic stem cell tr...
Show More Location
The Affiliated Hospital oh Xuzhou Medical University
Learn More & Join Trial
CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation PHASE1 This is a single-arm, open-label, phase I/II clinical trial initiated by in...
Show More Location
The First Affiliated Hospital of Zhengzhou University, Department of Oncology
Learn More & Join Trial
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant N/A The purpose of the study is to determine outcomes for Multiple Myeloma pati...
Show More Status
Active Not Recruiting
Location
Moffitt Cancer Center
Learn More & Join Trial
Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial PHASE2 Oral and intestinal mucositis are major risk factors for the occurrence of ...
Show More Location
Amsterdam UMC, location AMC
Learn More & Join Trial
High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas PHASE2 Central nervous system (CNS) relapses of aggressive lymphomas are a rare bu...
Show More Location
Charité Universitätsmedizin
Learn More & Join Trial
Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma PHASE3 The purpose of the study is to determine the best treatment approach based ...
Show More Location
Beth Israel Deaconess Medical Center (BIDMC)
Learn More & Join Trial
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma PHASE2 This phase II trial compares the impact of brentuximab vedotin and nivoluma...
Show More Location
Multiple Locations
Learn More & Join Trial
HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903 PHASE2 This is a Phase II multi-center trial single arm trial of autologous transp...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL) PHASE1 The goal of this clinical research study is to find the highest tolerable d...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients PHASE2 Clinical trial investigating the chemotherapeutic compound treosulfan (Trec...
Show More Location
Departement of Medical Oncology, University Hospital Berne
Learn More & Join Trial